HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lin Wu Selected Research

Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)

12/2021Requirement for containing etoposide in the initial treatment of lymphoma associated hemophagocytic lymphohistiocytosis.
1/2021Non-EBV infection-associated hemophagocytic lymphohistiocytosis: a distinct subgroup where pathogen-directed therapy is essential and favorable outcomes are expected.
4/2020[Dectection of Erythrocyte Life and Analysis of Its Effect on the Anemia in Patients with Hemophagocytic Syndrome].
1/2020Genotype characteristics and immunological indicator evaluation of 311 hemophagocytic lymphohistiocytosis cases in China.
1/2020Ruxolitinib for refractory/relapsed hemophagocytic lymphohistiocytosis.
2/2019Innovative analysis of predictors for overall survival from systemic non-Hodgkin T cell lymphoma using quantile regression analysis.
1/2018Primary hemophagocytic lymphohistiocytosis in adults: the utility of family surveys in a single-center study from China.
9/2017Elevation of CD16+CD56+ NK-cells and down-regulation of serum interleukin-21 (IL-21) and IL-1α after splenectomy in relapsed hemophagocytic lymphohistiocytosis of unknown cause.
11/2016Allogeneic hematopoietic stem-cell transplantation for adult and adolescent hemophagocytic lymphohistiocytosis: a single center analysis.
1/2016PEG-aspargase and DEP regimen combination therapy for refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lin Wu Research Topics

Disease

100Neoplasms (Cancer)
12/2022 - 08/2002
35Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2022 - 01/2013
19Lung Neoplasms (Lung Cancer)
03/2021 - 01/2013
17Inflammation (Inflammations)
04/2022 - 01/2012
17Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
12/2021 - 12/2008
12Neoplasm Metastasis (Metastasis)
11/2022 - 01/2011
12Fibrosis (Cirrhosis)
10/2022 - 11/2012
12Breast Neoplasms (Breast Cancer)
04/2022 - 07/2006
11Disease Progression
11/2022 - 12/2014
11Hypertension (High Blood Pressure)
10/2022 - 09/2014
11Colorectal Neoplasms (Colorectal Cancer)
10/2020 - 01/2011
10Hypoxia (Hypoxemia)
04/2022 - 01/2011
9Small Cell Lung Carcinoma (Small Cell Lung Cancer)
10/2022 - 01/2019
9Mitochondrial Diseases (Mitochondrial Disease)
08/2019 - 01/2013
9Torsades de Pointes (Torsade de Pointes)
01/2013 - 01/2004
8Acute Kidney Injury (Acute Renal Failure)
02/2022 - 01/2017
8Infections
01/2022 - 01/2011
8Lymphoma (Lymphomas)
12/2021 - 10/2009
8Carcinoma (Carcinomatosis)
01/2021 - 01/2010
8Ischemia
01/2021 - 04/2008
8Ventricular Tachycardia
01/2019 - 01/2004
8Carcinogenesis
12/2017 - 11/2012
7Brain Ischemia (Cerebral Ischemia)
04/2022 - 02/2015
7Obesity
04/2022 - 07/2010
7Heart Failure
01/2022 - 01/2013
7Cardiovascular Diseases (Cardiovascular Disease)
12/2021 - 09/2014
7Hepatocellular Carcinoma (Hepatoma)
11/2021 - 01/2013
6Esophageal Squamous Cell Carcinoma
01/2022 - 09/2015
6Necrosis
12/2021 - 08/2015
6Diabetic Nephropathies (Diabetic Nephropathy)
10/2021 - 01/2014
6Reperfusion Injury
10/2021 - 01/2013
6Atrial Fibrillation
10/2021 - 01/2004
6Cardiac Arrhythmias (Arrythmia)
01/2021 - 01/2009
6Proteinuria
10/2020 - 05/2018
6Rheumatoid Arthritis
10/2018 - 01/2010
6Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
10/2013 - 11/2012
5Fatigue
10/2022 - 10/2016
5Systemic Lupus Erythematosus (Libman-Sacks Disease)
10/2022 - 01/2010
5Hypertrophy
08/2022 - 03/2016
5Cardiomegaly (Heart Hypertrophy)
04/2022 - 03/2016
5Hemorrhage
03/2022 - 12/2013
5Chronic Renal Insufficiency
02/2022 - 07/2007
5Ischemic Stroke
10/2021 - 07/2015
5Fever (Fevers)
09/2021 - 09/2014
5Insulin Resistance
04/2021 - 01/2012
5Adenocarcinoma
01/2021 - 04/2014
5Myocardial Ischemia (Ischemic Heart Diseases)
01/2020 - 01/2013
5Body Weight (Weight, Body)
11/2016 - 01/2005
4Liver Cirrhosis (Hepatic Cirrhosis)
10/2022 - 01/2011
4Adenocarcinoma of Lung
03/2022 - 12/2020
4Stroke (Strokes)
12/2021 - 07/2009

Drug/Important Bio-Agent (IBA)

49Proteins (Proteins, Gene)FDA Link
10/2022 - 08/2005
29Biomarkers (Surrogate Marker)IBA
12/2022 - 01/2010
22Pharmaceutical PreparationsIBA
03/2022 - 08/2004
14Messenger RNA (mRNA)IBA
04/2022 - 12/2006
13ErbB Receptors (EGF Receptor)IBA
04/2022 - 01/2013
12Tyrosine Kinase InhibitorsIBA
11/2022 - 04/2013
12Cisplatin (Platino)FDA LinkGeneric
01/2021 - 07/2009
10DNA (Deoxyribonucleic Acid)IBA
12/2022 - 07/2006
10Indicators and Reagents (Reagents)IBA
05/2022 - 07/2012
10Rituximab (Mabthera)FDA Link
05/2014 - 11/2011
9anlotinibIBA
10/2022 - 11/2018
9Therapeutic UsesIBA
01/2022 - 07/2009
9Glucose (Dextrose)FDA LinkGeneric
10/2021 - 04/2008
8MicroRNAs (MicroRNA)IBA
06/2022 - 02/2016
8Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 09/2014
8Complement System Proteins (Complement)IBA
12/2020 - 11/2011
8SodiumIBA
10/2020 - 08/2004
7Immune Checkpoint InhibitorsIBA
01/2022 - 11/2018
7Neuroprotective AgentsIBA
01/2020 - 05/2012
6Gefitinib (Iressa)FDA Link
11/2022 - 01/2018
6PlatinumIBA
03/2022 - 02/2016
6Long Noncoding RNAIBA
11/2021 - 12/2015
6CholesterolIBA
04/2021 - 01/2005
6RanolazineFDA Link
01/2018 - 08/2004
5Oxygen (Dioxygen)IBA
12/2021 - 01/2015
5Reactive Oxygen Species (Oxygen Radicals)IBA
08/2021 - 01/2015
5CreatinineIBA
04/2021 - 01/2019
5Phosphotransferases (Kinase)IBA
01/2021 - 05/2013
5Biological ProductsIBA
12/2020 - 01/2013
5Hyaluronic Acid (Hyaluronan)IBA
09/2020 - 12/2018
5GlucocorticoidsIBA
11/2019 - 01/2012
5Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2018 - 01/2014
5Peptides (Polypeptides)IBA
07/2015 - 08/2005
5AutoantigensIBA
04/2013 - 01/2010
4Circulating Tumor DNAIBA
12/2022 - 01/2017
4RNA (Ribonucleic Acid)IBA
12/2022 - 01/2011
4ResistinIBA
04/2022 - 03/2016
4CateninsIBA
02/2022 - 01/2016
4Docetaxel (Taxotere)FDA Link
12/2021 - 04/2012
4NivolumabIBA
12/2021 - 01/2019

Therapy/Procedure

75Therapeutics
11/2022 - 03/2005
33Drug Therapy (Chemotherapy)
10/2022 - 01/2004
8Immunotherapy
03/2022 - 06/2018
6Radiotherapy
09/2021 - 03/2015
6Photothermal Therapy
11/2020 - 09/2013
5Neoadjuvant Therapy
01/2022 - 05/2010
5Aftercare (After-Treatment)
08/2020 - 07/2009
5Intravenous Injections
01/2020 - 09/2013
4Length of Stay
03/2022 - 05/2013